Short-term intravenous interferon therapy for chronic hepatitis B
Author(s) -
Hiroaki Okushin,
Toru Ohnishi,
Kazuhiko Morii,
Koichi Uesaka,
Shiro Yuasa
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.3038
Subject(s) - medicine , hbeag , gastroenterology , alpha interferon , seroconversion , pegylated interferon , hbsag , adverse effect , alanine transaminase , hepatitis b , immunology , interferon alfa , hepatitis b virus , interferon , pharmacology , chronic hepatitis , virus , ribavirin
To investigate the therapeutic efficacy of short-term, multiple daily dosing of intravenous interferon (IFN) in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom